Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : LLY    crawled date : 2021 - 02 - 10    save search
Etesevimab (JS016) Administered with Bamlanivimab Receives FDA Emergency Use Authorization for COVID-19
Published: 2021-02-10 (Crawled : 08:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
 | | O: 1.37% H: 0.53% C: -0.04%
covid fda merge authorized covid-19 emergency use authorization
AbCellera-Discovered Antibody, Bamlanivimab, Administered with Etesevimab Receives FDA Emergency Use Authorization for COVID-19
Published: 2021-02-10 (Crawled : 07:00) - biospace.com/
ABCL | $3.88 -0.77% -0.77% 980K twitter stocktwits trandingview |
| | O: 12.77% H: 0.06% C: -11.34%
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
 | | O: 1.37% H: 0.53% C: -0.04%
covid fda antibody merge authorized covid-19 emergency use authorization
Lilly's bamlanivimab (LY-CoV555) administered with etesevimab (LY-CoV016) receives FDA emergency use authorization for COVID-19
Published: 2021-02-10 (Crawled : 01:15) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
 | | O: 1.37% H: 0.53% C: -0.04%
covid fda merge authorized emergency use authorization
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.